Latest article
SCM Lifescience to in-license iPSCs-based diabetes drug from U.S. agency
SCM Lifescience has agreed to license a diabetes drug that uses pancreatic beta cells derived from induced pluripotent stem cells...
Zegalogue Authorised for Extreme Hypoglycemia in Sufferers With Diabetes
The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...
